Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients

被引:12
作者
Altun, B
Yilmaz, R
Kahraman, S
Gençtoy, G
Arici, M
Önalan, O
Oto, A
Hayran, M
Bakkaloglu, M
Yasavul, Ü
Turgan, Ç
机构
[1] Hacettepe Univ, Fac Med, Dept Internal Med, Div Nephrol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Radiol, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Canc Epidemiol, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Dept Urol, TR-06100 Ankara, Turkey
关键词
cardiovascular disease; cytokine; transplantation;
D O I
10.1111/j.1432-2277.2005.00118.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cardiovascular events are the leading causes of morbidity and mortality in renal transplant recipients (RTR). Given the role of inflammation in atherosclerosis, the contribution of functional polymorphisms of cytokines to cardiovascular diseases (CVD) was assessed in RTR in this study. Polymorphisms of tumour necrosis factor alpha (TNF-alpha) gene [-308 (G -> A), -238 (G -> A)], interleukin-10 (IL-10) gene [-1082(A -> G), -819 (T -> C)], -592 (A -> C), transforming growth factor beta 1 (TGF-beta 1) gene [codon 10 (T -> C), codon 25 (G -> C)], carotis intima media thickness (CIMT), left ventricular mass index (LVMI), 24-h ambulatory blood pressure and serum lipoprotein homocysteine level, erythrocyte sedimentation rate, serum C-reactive protein (CRP) and serum fibrinogen level of RTR were determined. Seventy-two RTR (26 cadaveric allograft, 46 living-related allograft, 43 male, 29 female) were included in this study. LVMI were similar in TNF-alpha, IL-10 and TGF-beta 1 genotypes. Right and left CIMT were higher in TT genotype (n = 16) than CT (n = 46) and CC (n = 10) genotypes of TGF-beta 1 codon 10 (T -> C) gene polymorphism (RCIMT, 7.7 +/- 2.2 mm vs. 7.0 +/- 1.4 mm vs. 5.9 +/- 1.4 mm, P = 0.025; LCIMT, 8.5 +/- 2.5 mm vs. 7.0 +/- 1.3 mm vs. 6.1 +/- 1.2 mm, P = 0.002). Lipoprotein (a) level of TT genotype (35.5 +/- 22.5 mg/dl) was higher than CC (4.1 +/- 2.8 mg/dl) and CT (20.4 +/- 11.2 mg/dl) genotypes of TGF-beta 1 codon 10 (T -> C) gene polymorphism (P = 0.037). High producers of cytokine IL-10 -1082 [GG (n = 22) vs. AA + AG (n = 50)] and low producers of TGF-beta codon 25 [GC + CC (n = 17) vs. GG (n = 55)] had lower IMT of carotid artery but the difference did not reach statistical significance (P > 0.05). The CIMT of renal transplant patients was similar in IL-10 (-819, -592) and TNF-alpha (-308, -238) genotypes. No difference was observed in 24-h ambulatory blood pressure levels, serum lipoproteins, plasma homocysteine level, erythrocyte sedimentation rate, serum CRP, serum fibrinogen level in IL-10, TNF-alpha and TGF-beta 1 genotypes. Besides the well-known factors, TGF-beta 1 gene polymorphisms might play a role in CVD in RTR even at early stages of asymptomatic atherosclerosis.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
[21]   Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events [J].
Mansell, Holly ;
Soliman, Mahmoud ;
Elmoselhi, Hamdi ;
Shoker, Ahmed .
PLOS ONE, 2015, 10 (11)
[22]   Urinary Proinflammatory Cytokine Response in Renal Transplant Recipients With Polyomavirus BK Viruria [J].
Sadeghi, Mahmoud ;
Daniel, Volker ;
Schnitzler, Paul ;
Lahdou, Imad ;
Naujokat, Cord ;
Zeier, Martin ;
Opelz, Gerhard .
TRANSPLANTATION, 2009, 88 (09) :1109-1116
[23]   Transplant clinical pharmacy services improve cardiovascular risk factor management and control in Veteran organ transplant recipients [J].
Elmaasarani, Zana ;
Schumann, Eric ;
Taber, David J. .
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (03) :280-287
[24]   The impact of early cytomegalovirus infection and disease in renal transplant recipients [J].
Sagedal, S ;
Hartmann, A ;
Rollag, H .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (07) :518-530
[25]   Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients [J].
Hartog, Jasper W. L. ;
de Vries, Aiko P. J. ;
Bakker, Stephan J. L. ;
Graaff, Reindert ;
van Son, Willem J. ;
van der Heide, Jaap J. Homan ;
Gans, Reinold O. B. ;
Wolffenbuttel, Bruce H. R. ;
de Jong, Paul E. ;
Smit, Andries J. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) :2263-2269
[26]   Subclinical atherosclerosis and related risk factors in renal transplant recipients [J].
Mitra Basiratnia ;
Mojtaba Fazel ;
Mehrzad Lotfi ;
Ghamar Hosseini Al-Hashemi ;
Mohammad Hossein Fallahzadeh ;
Ali Derakhshan ;
Mahdi Salehipour .
Pediatric Nephrology, 2010, 25 :343-348
[27]   Risk factors for chronic renal dysfunction in lung transplant recipients [J].
Esposito, Ciro ;
De Mauri, Andreana ;
Vitulo, Patrizio ;
Oggionni, Tiberio ;
Cornacchia, Flavia ;
Valentino, Rossella ;
Grosjean, Fabrizio ;
Torreggiani, Massimo ;
Dal Canton, Antonio .
TRANSPLANTATION, 2007, 84 (12) :1701-1703
[28]   Cardiovascular morbidity and risk factors in renal transplant patients [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) :648-654
[29]   Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients [J].
Irish, AB ;
Green, FR .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) :167-173
[30]   Cancers in renal transplant recipients [J].
Penn, I .
ADVANCES IN RENAL REPLACEMENT THERAPY, 2000, 7 (02) :147-156